1. Academic Validation
  2. Acid Sphingomyelinase and Acid β-Glucosidase 1 Exert Opposite Effects on Interleukin-1β-Induced Interleukin 6 Production in Rheumatoid Arthritis Fibroblast-Like Synoviocytes

Acid Sphingomyelinase and Acid β-Glucosidase 1 Exert Opposite Effects on Interleukin-1β-Induced Interleukin 6 Production in Rheumatoid Arthritis Fibroblast-Like Synoviocytes

  • Inflammation. 2021 Aug;44(4):1592-1606. doi: 10.1007/s10753-021-01444-9.
Mengmeng Zhao 1 Maowei Yang 2 Xu Li 2 Linxin Hou 3 Xudong Liu 4 Weiguo Xiao 5
Affiliations

Affiliations

  • 1 Department of Rheumatology and Immunology, The First Hospital of China Medical University, No.155 North Nanjing Street, Shenyang, 110001, China.
  • 2 Department of Orthopedics, The First Hospital of China Medical University, Shenyang, China.
  • 3 Department of Rheumatology and Immunology, Sheng Jing Hospital of China Medical University, Shenyang, China.
  • 4 Department of Rheumatology and Immunology, The First Hospital of China Medical University, No.155 North Nanjing Street, Shenyang, 110001, China. 2418264813@qq.com.
  • 5 Department of Rheumatology and Immunology, The First Hospital of China Medical University, No.155 North Nanjing Street, Shenyang, 110001, China. xonet5670@163.com.
Abstract

Acid sphingomyelinase (ASM) and acid β-glucosidase 1 (GBA1) catalyze ceramide formation through different routes, and both are involved in rheumatoid arthritis (RA) pathogenesis as well as IL-6 production. However, whether ASM and GBA1 regulate IL-6 production in RA remains unknown. Serum ASM, GBA1, and ceramide levels were measured in RA patients and healthy controls by enzyme-linked immunosorbent assay, and their correlations with clinical Indicators of patients were evaluated. Pharmacologic inhibitors or small hairpin RNAs of ASM and GBA1 were employed to explore the roles of ASM and GBA1 in IL-6 production, cell behavior, and MAPK signaling in fibroblast-like synoviocytes from RA patients (RAFLS). ASM, GBA1, and ceramide serum levels were significantly elevated in patients with RA. GBA1 and ceramide serum levels were negatively and positively correlated with IL-6 serum level in RA patients, respectively. ASM inhibitor or knockdown of ASM abolished IL-1β-induced IL-6 expression and secretion. Functionally, ASM inhibitor suppressed IL-1β-induced cell proliferation, migration, and invasion in RAFLS. Mechanistically, ASM inhibitor or knockdown of ASM effectively countered IL-1β-induced activation of p38 MAPK signaling. The pharmacologic inhibitor or knockdown of GBA1 exhibited the opposite effects. Importantly, p38 inhibitor blocked IL-1β-induced IL-6 production in RAFLS. ASM plays a pathogenic role in RA, whereas GBA1 plays a protective role in RA possibly by regulating IL-6 production in RAFLS at least partially via p38 signaling, serving as potential therapeutic targets in RA treatment.

Keywords

acid sphingomyelinase; acid β-glucosidase 1; ceramide; interleukin 6; mitogen-activated protein kinase p38; rheumatoid arthritis.

Figures
Products